Device / Technology News

RSS

EyeLock named as 2015 CES Innovation Awards Honoree for myris

EyeLock Inc., a market leader of iris-based identity authentication solutions, today announced that it has been named a 2015 CES Innovation Awards Honoree for myris. Products entered in this prestigious program are judged by a preeminent panel of independent industrial designers, independent engineers and members of the trade media to honor outstanding design and engineering in cutting edge consumer electronics products across 28 product categories.

12 Nov 2014

Amedica, Spinal Kinetics sign multi-year OEM agreement for silicon nitride spinal implants

Amedica Corporation, a biomaterial company that has developed silicon nitride ceramics as a material platform to manufacture and commercialize orthopedic implants, is pleased to announce that it has entered into a multi-year original equipment manufacturer (OEM) agreement with Spinal Kinetics, a leading innovator of advanced spinal implant technologies.

12 Nov 2014

MEDICREA receives FDA clearance for world’s first patient-specific spinal osteosynthesis rod

The MEDICREA Group, a company that specializes in the development of personalized implants produced for a patient’s specific need in the treatment of spinal pathologies, today announced the company has received 510(k) clearance from the U.S. Food and Drug Administration for UNiD, the world’s first patient-specific spinal osteosynthesis rod.

12 Nov 2014

Funding makes next-generation scientific equipment available to CBC research community

The Chicago Biomedical Consortium is announcing a $3 million Infrastructure Initiative to promote investment in high-impact, next-generation scientific equipment at its member universities. The Initiative aims to make modern and powerful tools available to the CBC research community at a time when federal grants for scientific infrastructure are scarce.

12 Nov 2014

Crescendo Bioscience to present new data on Vectra DA at ACR Annual Meeting

Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, Inc., today announced that new data on Vectra DA will be featured at the 2014 American College of Rheumatology Annual Meeting, Nov. 15-19, 2014, in Boston, Massachusetts.

12 Nov 2014

ViewRay's MRIdian system gets CE Mark approval

ViewRay, a privately held medical device company, announced today that its MRIdian (me-rid-i-an) system, the world's first and only MRI-guided radiation therapy system, has received CE Mark (Conformite Europeenne) approval.

11 Nov 2014

Actamax reports positive results from first clinical study of novel sprayable adhesion barrier device

Actamax Surgical Materials LLC, a DSM-DuPont Joint Venture focusing on the development and commercialization of resorbable, biocompatible surgical medical devices, today announced positive safety and efficacy results from the first clinical evaluation of its novel adhesion barrier device.

11 Nov 2014

Arches Health Plan forms new partnership to create consumer-focused education app

Arches Health Plan announced today that it has partnered with the University of Utah Entertainment Arts and Engineering program and the Sorenson Center for Discovery & Innovation in the creation of a consumer focused education app.

11 Nov 2014

Researchers refine diagnostic tools to predict treatment outcomes for children with neuroblastoma

Oncology researchers studying gene mutations in the childhood cancer neuroblastoma are refining their diagnostic tools to predict which patients are more likely to respond to drugs called ALK inhibitors that target such mutations. Removing some of the guesswork in diagnosis and treatment, the researchers say, may lead to more successful outcomes for children with this often-deadly cancer.

11 Nov 2014

Lung cancer screening in NLST meets standard for cost effectiveness

Dartmouth researchers say lung cancer screening in the National Lung Screening Trial (NLST) meets a commonly accepted standard for cost effectiveness as reported in the Nov. 6 issue of the New England Journal of Medicine. This relatively new screening test uses annual low-dose CT scans to spot lung tumors early in individuals facing the highest risks of lung cancer due to age and smoking history.

11 Nov 2014

Peter Munk Cardiac Centre surgeons successfully implant novel heart device

A surgical team at the Peter Munk Cardiac Centre led by internationally-acclaimed cardiovascular surgeon, Dr. Vivek Rao, has successfully implanted a novel mechanical device, the HeartMate IIITM, into a patient with advanced heart failure.

11 Nov 2014

MicroMatrices, Advanced Cell Diagnostics sign preferred partnership agreement

MicroMatrices, a service provider specialised in high resolution cell type-specific analysis to characterise toxicological responses in different cell types in tissue, today announced a preferred partnership agreement with Advanced Cell Diagnostics, Inc., a leader in the field of molecular pathology and developer of cell and tissue-based analysis tools.

From Advanced Cell Diagnostics 11 Nov 2014

Olympus to host fifth annual neuroimaging symposium in conjunction with 2014 annual meeting of the Society for Neuroscience

Olympus is hosting its fifth annual neuroimaging symposium in conjunction with the 2014 annual meeting of the Society for Neuroscience (SfN) on Monday, November 17 at 6:30pm in Washington DC. The Olympus Neuroimaging Symposium and reception will be held at the Marriott Marquis Washington, DC, 901 Massachusetts Avenue NW, in the Capitol and Congress ballrooms. It is open to all media and registered SfN attendees.

From Evident Corporation - Life Sciences 10 Nov 2014

New interactive private messaging feature now available via DentalPost website, mobile application

In its effort to continually innovate how dental professionals connect and create teams that excel, DentalPost, the dental industry's premier online and mobile job board, announces today it has launched an interactive private messaging feature.

10 Nov 2014

FDA approves ImThera Medical's investigational device exemption for pivotal study

ImThera Medical, Inc., a privately held global medical device company, today announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for its THN3 Clinical Study.

10 Nov 2014

Resonance Health launches new diagnostic imaging solution for patients with fatty liver disease

ASX listed Resonance Health officially launched an innovative new diagnostic imaging solution for liver patients worldwide at the American Association for the Study of Liver Diseases annual conference in Boston this week.

10 Nov 2014

CytoFLEX flow cytometer from Beckman Coulter Life Sciences delivers full analysis capabilities

Surpassing the performance expectations of full-size, top-line analyzers, the CytoFLEX flow cytometer (www.

From Beckman Coulter Life Sciences - Flow Cytometry 10 Nov 2014

SQI Diagnostics gets FDA clearance to market Celiac Panel in the US

SQI Diagnostics Inc. today announced that it has received notice that the United States Food and Drug Administration has cleared the Company to market its proprietary Celiac Panel in the United States (US).

8 Nov 2014

Ipsen receives approval from FDA for new device designed to deliver Somatuline Depot Injection

Ipsen Biopharmaceuticals, Inc., an affiliate of Ipsen, today announced that the U.S. Food and Drug Administration (FDA) has approved a new device to deliver Somatuline Depot (lanreotide). The device has an enhanced, prefilled, low-volume syringe that supports full-dose delivery with no reconstitution requirements.

7 Nov 2014

New algorithm could help determine how to treat patients having difficulty breathing

Paramedics respond to a 911 call to find an elderly patient who's having difficulty breathing. Anxious and disoriented, the patient has trouble remembering all the medications he's taking, and with his shortness of breath, speaking is difficult. Is he suffering from acute emphysema or heart failure? The symptoms look the same, but initiating the wrong treatment regimen will increase the patient's risk of severe complications.

7 Nov 2014

Device / Technology News

EyeLock named as 2015 CES Innovation Awards Honoree for myris

Amedica, Spinal Kinetics sign multi-year OEM agreement for silicon nitride spinal implants

MEDICREA receives FDA clearance for world’s first patient-specific spinal osteosynthesis rod

Funding makes next-generation scientific equipment available to CBC research community

Crescendo Bioscience to present new data on Vectra DA at ACR Annual Meeting

ViewRay's MRIdian system gets CE Mark approval

Actamax reports positive results from first clinical study of novel sprayable adhesion barrier device

Arches Health Plan forms new partnership to create consumer-focused education app

Researchers refine diagnostic tools to predict treatment outcomes for children with neuroblastoma

Lung cancer screening in NLST meets standard for cost effectiveness

Peter Munk Cardiac Centre surgeons successfully implant novel heart device

MicroMatrices, Advanced Cell Diagnostics sign preferred partnership agreement

Olympus to host fifth annual neuroimaging symposium in conjunction with 2014 annual meeting of the Society for Neuroscience

New interactive private messaging feature now available via DentalPost website, mobile application

FDA approves ImThera Medical's investigational device exemption for pivotal study

Resonance Health launches new diagnostic imaging solution for patients with fatty liver disease

CytoFLEX flow cytometer from Beckman Coulter Life Sciences delivers full analysis capabilities

SQI Diagnostics gets FDA clearance to market Celiac Panel in the US

Ipsen receives approval from FDA for new device designed to deliver Somatuline Depot Injection

New algorithm could help determine how to treat patients having difficulty breathing

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Latest News